Bexion Pharmaceuticals, Inc. Presents Clinical Data at 2018 SNO Annual Meeting
FOR IMMEDIATE RELEASE Covington, KY, November 19, 2018 - Bexion Pharmaceuticals, Inc., a clinical - stage biopharmaceutical company focused on rare brain and solid tumors, announced today that a clinical oral report followed by poster review and a second case study poster were presented at the Society of Neuro